Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor γ expression in human skeletal muscle

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4293-4297

  Lapsys, Naras M ^a   Kriketos, Adamandia D ^a   Lim Fraser, Megan ^a   Poynten, Ann M ^a   Lowy, Andrew ^a   Furler, Stuart M ^a   Chisholm, Donald J ^a   Cooney, Gregory J ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID BINDING PROTEIN; GLUCOSE TRANSPORTER; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

AGED; BLOOD GLUCOSE; CARNITINE ACYLTRANSFERASES; CARRIER PROTEINS; COMPLEMENT FACTOR D; FATTY ACID-BINDING PROTEINS; FATTY ACIDS, NONESTERIFIED; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEOPLASM PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; TRANSCRIPTION FACTORS; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEINS;

EID: 0034527587     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.11.4293     Document Type: Article

References (22)

1. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists
2. The organization, promoter analysis, and expression of the human PPARγ gene
3. PPARγ3 mRNA: A distinct PPARγ mRNA subtype transcribed from an independent promoter
4. Role of the peroxisome proliferator activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
5. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation
6. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
7. Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM
8. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects
9. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARγ and PPARγ activators
10. PPARcα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
11. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat
12. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat
13. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids
14. PPAR-γ gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
15. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-γ in human adipocytes
16. A fluorometric assay for the quantification of RNA in solution with nanogram sensitivity
17. Skeletal muscle peroxisome proliferator-activated receptor-γ expression in obesity and non- insulin-dependent diabetes mellitus
18. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor
19. The glucose-fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
20. Regulation of PPAR gene expression by nutrition and obesity in rodents
21. Depot-specific differences in adipose tissue gene expression in lean and obese subjects
22. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ